Effects of a TELephone Counselling Intervention by Pharmacist (TelCIP) on medication adherence, patient beliefs and satisfaction with information for patients starting treatment: study protocol for a cluster randomized controlled trial

BMC Health Services Research

Marcel L Bouvy¹  Liset van Dijk²  Eibert R Heerdink¹  Erica CG van Geffen¹  Marcel J Kooy¹ 

[1] Department of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, P.O. Box 80082, Utrecht 3508 TB, The Netherlands;Netherlands Institute for Health Services Research (NIVEL), P.O. Box 1568, Utrecht 3500, BN The Netherlands

关键词: Patient centered care;    Medication adherence;    Patient education;    Remote consultation;    Telephone;    Pharmacists;    Interventions;   

Others  :  1131156
DOI  :  10.1186/1472-6963-14-219

 received in 2013-08-20, accepted in 2014-05-07,  发布年份 2014

【 摘 要 】

Background

Adherence to medication is often low. Pharmacists may improve adherence, but a one-size-fits-all approach will not work: different patients have different needs. Goal of the current study is to assess the effectiveness of a patient-tailored, telephone-based intervention by a pharmacist at the start of pharmacotherapy aimed at improving medication adherence, satisfaction with information and counselling and the beliefs about medicines.

Methods/Design

A cluster randomized controlled intervention trial in 30 Dutch pharmacies, randomly assigned to 1 of 2 intervention groups. Each group consists of an intervention arm and an usual care arm. The intervention arm in the first group is the usual care arm in the second group and vice versa. One intervention arm focuses on patients starting with antidepressants or bisphosphonates and the other on antilipaemic drugs or renin angiotensin system (RAS)-inhibitors. The intervention consists of a telephone call by a pharmacist 2 or 3 weeks after a new prescription. A random sample of pharmacies will send questionnaires 3 months after the first prescription. This contains socio-demographic questions, a measure of beliefs about medicines (BMQ), satisfaction with information received (SIMS, abbreviated) and frequency of pharmacy counselling (Consumer Quality Index, CQI, abbreviated). The primary outcome measure will be medication adherence calculated from dispensing records retrieved 12 months after the intervention. Patients’ beliefs on medication, perception of the quality of information received and pharmacy counselling are secondary outcomes.

Discussion

The TelCIP study will determine the effectiveness of telephone counselling to improve adherence in patients initiating a new treatment. By measuring satisfaction with information and counselling and beliefs about medication the study will also give clues for the reason of a potential increase in adherence. Finally the study will provide information on which patients are most likely to benefit from this intervention.

Trial registration

The trial is registered at http://www.trialregister.nl webcite under the identifier NTR3237.

【 授权许可】

   
2014 Kooy et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Osterberg L, Blaschke T: Adherence to medication. N Engl J Med 2005, 353(5):487-497.
• [2]van Geffen EC, Gardarsdottir H, van Hulten R, van Dijk L, Egberts AC, Heerdink ER: Initiation of antidepressant therapy: do patients follow the GP’s prescription? Br J Gen Pract 2009, 59(559):81-87.
• [3]WHO: ADHERENCE TO LONG-TERM THERAPIES Evidence for action. 2003.
• [4]Phatak HM, Thomas J 3rd: Relationships between beliefs about medications and nonadherence to prescribed chronic medications. Ann Pharmacother 2006, 40(10):1737-1742.
• [5]van Geffen EC, Kruijtbosch M, Egberts AC, Heerdink ER, van Hulten R: Patients’ perceptions of information received at the start of selective serotonin-reuptake inhibitor treatment: implications for community pharmacy. Ann Pharmacother 2009, 43(4):642-649.
• [6]van Geffen EC, van Hulten R, Bouvy ML, Egberts AC, Heerdink ER: Characteristics and reasons associated with nonacceptance of selective serotonin-reuptake inhibitor treatment. Ann Pharmacother 2008, 42(2):218-225.
• [7]Urquhart J, Vrijens B: New findings about patient adherence to prescribeddrug dosing regimens: an introduction to pharmionics. Eur J Hosp Pharm Sci 2005, 5:103.
• [8]Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, Dobbels F, Fargher E, Morrison V, Lewek P, Matyjaszczyk M, Mshelia C, Clyne W, Aronson JK, Urquhart J, ABC Project Team: A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 2012, 73(5):691-705.
• [9]Lamberts EJF, Bouvy ML, Hulten RP: The role of the community pharmacist in fulfilling information needs of patients starting oral antidiabetics. Res Soc Adm Pharm 2010, 6(4):354-364.
• [10]Feifer RA, Greenberg L, Rosenberg-Brandl S, Franzblau-Isaac E: Pharmacist counseling at the start of therapy: patient receptivity to offers of in-person and subsequent telephonic clinical support. Popul Health Manag 2010, 13(4):189-193.
• [11]Koo MM, Krass I, Aslani P: Factors influencing consumer use of written drug information. Ann Pharmacother 2003, 37(2):259-267.
• [12]Melnyk PS, Shevchuk YM, Remillard AJ: Impact of the dial access drug information service on patient outcome. Ann Pharmacother 2000, 34(5):585-592.
• [13]Kessels RP: Patients’ memory for medical information. J R Soc Med 2003, 96(5):219-222.
• [14]Linn AJ, van Dijk L, Smit EG, Jansen J, van Weert JC: May you never forget what is worth remembering: the relation between recall of medical information and medication adherence in patients with inflammatory bowel disease. J Crohns Colitis 2013, 7(11):e543-e550.
• [15]Sleath B, Wurst K, Lowery T: Drug information sources and antidepressant adherence. Community Ment Health J 2003, 39(4):359-368.
• [16]Arbuthnott A, Sharpe D: The effect of physician-patient collaboration on patient adherence in non-psychiatric medicine. Patient Educ Couns 2009, 77(1):60-67.
• [17]Kane SV, Robinson A: Review article: understanding adherence to medication in ulcerative colitis - innovative thinking and evolving concepts. Aliment Pharmacol Ther 2010, 32(9):1051-1058.
• [18]Linn AJ, van Weert JC, Schouten BC, Smit EG, van Bodegraven AA, van Dijk L: Words that make pills easier to swallow: a communication typology to address practical and perceptual barriers to medication intake behavior. Patient Prefer Adherence 2012, 6:871-885.
• [19]Elliott RA, Barber N, Clifford S, Horne R, Hartley E: The cost effectiveness of a telephone-based pharmacy advisory service to improve adherence to newly prescribed medicines. Pharm World Sci 2008, 30(1):17-23.
• [20]Wu JY, Leung WY, Chang S, Lee B, Zee B, Tong PC, Chan JC: Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. BMJ 2006, 333(7567):522.
• [21]Jones CJ, Smith HE, Frew AJ, Du Toit G, Mukhopadhyay S, Llewellyn CD: Explaining adherence to self-care behaviours amongst adolescents with food allergy: A comparison of the health belief model and the common sense self-regulation model. Br J Health Psychol 2013, 19(1):65-82.
• [22]Rosenstock IM: Why people use health services. Milbank Mem Fund Q 1966, 44(Suppl 3):94-127.
• [23]Greenhill N, Anderson C, Avery A, Pilnick A: Analysis of pharmacist–patient communication using the Calgary-Cambridge guide. Patient Educ Couns 2011, 83(3):423-431.
• [24]Hess LM, Raebel MA, Conner DA, Malone DC: Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 2006, 40(7–8):1280-1288.
• [25]Horne R: The Beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999, 14:1-24.
• [26]Aikens JE, Nease DE Jr, Nau DP, Klinkman MS, Schwenk TL: Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. Ann Fam Med 2005, 3(1):23-30.
• [27]Menckeberg TT, Bouvy ML, Bracke M, Kaptein AA, Leufkens HG, Raaijmakers JA, Horne R: Beliefs about medicines predict refill adherence to inhaled corticosteroids. J Psychosom Res 2008, 64(1):47-54.
• [28]Tibaldi G, Clatworthy J, Torchio E, Argentero P, Munizza C, Horne R: The utility of the Necessity–Concerns Framework in explaining treatment non-adherence in four chronic illness groups in Italy. Chronic Illn 2009, 5(2):129-133.
• [29]Horne R, Hankins M, Jenkins R: The Satisfaction with Information about Medicines Scale (SIMS): a new measurement tool for audit and research. Qual Health Care 2001, 10(3):135-140.
• [30]van Greuningen M, Vervloet M, van der Hoek L, van Dijk L: Het discriminerend vermogen van de CQ-index Farmaceutische Zorg. 2009.
• [31]van Geffen EC, Philbert D, van Boheemen C, van Dijk L, Bos MB, Bouvy ML: Patients’ satisfaction with information and experiences with counseling on cardiovascular medication received at the pharmacy. Patient Educ Couns 2011, 83(3):303-309.
• [32]Campbell MJ, Julious SA, Altman DG: Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ 1995, 311(7013):1145-1148.
• [33]Gadkari AS, McHorney CA: Unintentional non-adherence to chronic prescription medications: How unintentional is it really? BMC Health Serv Res 2012, 12(1):98. BioMed Central Full Text